Vineet Laborator

40
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE505Y01010
  • NSEID: VINEETLAB
  • BSEID: 543298
INR
37.80
1.8 (5.0%)
BSENSE

May 06

BSE+NSE Vol: 2.36 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -50.20% vs -29.06% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -326.15% vs -6.00% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -16.80% vs 41.44% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -2,065.83% vs -18.00% in Mar 2024

Compare Profit and Loss Results of Vineet Laborator
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
74.00
114.00
-40.00
-35.09%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
74.00
114.00
-40.00
-35.09%
Expenditure (Ex Depriciation)
Stock Adjustments
6.00
0.00
6.00
0%
Raw Materials Consumed
63.00
97.00
-34.00
-35.05%
Power & Fuel Cost
3.00
0.00
3.00
0%
Employee Cost
5.00
2.00
3.00
150.00%
Operating Expenses
8.00
0.00
8.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1.00
6.00
-5.00
-83.33%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
91.00
111.00
-20.00
-18.02%
Operating Profit (PBDIT) excl Other Income
-16.00
3.00
-19.00
-633.33%
Other Income
1.00
2.00
-1.00
-50.00%
Operating Profit (PBDIT)
-14.00
5.00
-19.00
-380.00%
Interest
3.00
0.00
3.00
0%
Profit before Depriciation and Tax
-18.00
5.00
-23.00
-460.00%
Depreciation
2.00
1.00
1.00
100.00%
Profit Before Taxation & Exceptional Items
-20.00
4.00
-24.00
-600.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-20.00
4.00
-24.00
-600.00%
Provision for Tax
0.00
0.00
0.00
0%
Profit After Tax
-20.00
3.00
-23.00
-766.67%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
14.00
8.00
6.00
75.00%
Profit Available for appropriations
-5.00
12.00
-17.00
-141.67%
Appropriations
-5.00
12.00
-17.00
-141.67%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-21.9
0.2
-22.10
-11,050.00%
Profit And Loss - Net Sales
Net Sales 75.00 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -50.20% vs -29.06% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -16.28 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -326.15% vs -6.00% in Mar 2024

Profit And Loss - Interest
Interest 3.98 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -16.80% vs 41.44% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax -20.19 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -2,065.83% vs -18.00% in Mar 2024